82 related articles for article (PubMed ID: 38560563)
21. Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment.
Ho M; Xiao A; Yi D; Zanwar S; Bianchi G
Curr Oncol; 2022 Nov; 29(11):8975-9005. PubMed ID: 36421358
[TBL] [Abstract][Full Text] [Related]
22. Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma.
Wang H; Tang F; Tang P; Zhang L; Gan Q; Li Y
Aging (Albany NY); 2022 Oct; 14(19):8013-8031. PubMed ID: 36227151
[TBL] [Abstract][Full Text] [Related]
23. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.
Jabbour E; Kantarjian H
Am J Hematol; 2022 Sep; 97(9):1236-1256. PubMed ID: 35751859
[TBL] [Abstract][Full Text] [Related]
24. Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.
Bou Zerdan M; Nasr L; Kassab J; Saba L; Ghossein M; Yaghi M; Dominguez B; Chaulagain CP
Int J Hematol Oncol; 2022 Apr; 11(2):IJH39. PubMed ID: 35663420
[TBL] [Abstract][Full Text] [Related]
25. N
Lin X; Wang F; Chen J; Liu J; Lin YB; Li L; Chen CB; Xu Q
Mil Med Res; 2022 Apr; 9(1):19. PubMed ID: 35418160
[TBL] [Abstract][Full Text] [Related]
26. Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma.
Wang H; Xiao X; Li Z; Luo S; Hu L; Yi H; Xiang R; Zhu Y; Wang Y; Zhu L; Xiao L; Dai C; Aziz A; Yuan L; Cui Y; Li R; Gong F; Liu X; Liang L; Peng H; Zhou H; Liu J
Cancer Lett; 2022 Jul; 537():215647. PubMed ID: 35306105
[TBL] [Abstract][Full Text] [Related]
27. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
[TBL] [Abstract][Full Text] [Related]
29. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of CD34
Li X; Dai Y; Chen B; Huang J; Chen S; Jiang L
Front Med; 2021 Aug; 15(4):608-620. PubMed ID: 33754282
[TBL] [Abstract][Full Text] [Related]
31. The function and pathogenic mechanism of filamin A.
Zhou J; Kang X; An H; Lv Y; Liu X
Gene; 2021 Jun; 784():145575. PubMed ID: 33737122
[TBL] [Abstract][Full Text] [Related]
32. Game of Bones: How Myeloma Manipulates Its Microenvironment.
Moser-Katz T; Joseph NS; Dhodapkar MV; Lee KP; Boise LH
Front Oncol; 2020; 10():625199. PubMed ID: 33634031
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma.
Fang Y; Hou J
Mil Med Res; 2021 Jan; 8(1):9. PubMed ID: 33504363
[TBL] [Abstract][Full Text] [Related]
34. TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression.
Li L; Wei JR; Song Y; Fang S; Du Y; Li Z; Zeng TT; Zhu YH; Li Y; Guan XY
Cell Death Dis; 2021 Jan; 12(1):125. PubMed ID: 33500384
[TBL] [Abstract][Full Text] [Related]
35. Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma.
Suzuki K; Nishiwaki K; Yano S
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435539
[TBL] [Abstract][Full Text] [Related]
36. The p53 Pathway and Metabolism: The Tree That Hides the Forest.
Lahalle A; Lacroix M; De Blasio C; Cissé MY; Linares LK; Le Cam L
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33406607
[TBL] [Abstract][Full Text] [Related]
37. Silencing
Zhu Q; Ren H; Li X; Qian B; Fan S; Hu F; Xu L; Zhai B
Aging (Albany NY); 2020 Nov; 12(22):22975-23003. PubMed ID: 33203790
[TBL] [Abstract][Full Text] [Related]
38. Autonomic nervous system control of multiple myeloma.
Cheng Y; Sun F; D'Souza A; Dhakal B; Pisano M; Chhabra S; Stolley M; Hari P; Janz S
Blood Rev; 2021 Mar; 46():100741. PubMed ID: 32807576
[TBL] [Abstract][Full Text] [Related]
39. Dabrafenib and Trametinib in Patients With Tumors With
Salama AKS; Li S; Macrae ER; Park JI; Mitchell EP; Zwiebel JA; Chen HX; Gray RJ; McShane LM; Rubinstein LV; Patton D; Williams PM; Hamilton SR; Armstrong DK; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
J Clin Oncol; 2020 Nov; 38(33):3895-3904. PubMed ID: 32758030
[TBL] [Abstract][Full Text] [Related]
40. Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis.
Peng Y; Wu D; Li F; Zhang P; Feng Y; He A
Cancer Cell Int; 2020; 20():262. PubMed ID: 32581652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]